It is unclear. Pseudoephedrine causes an average increase of 1.2 mm Hg in systolic blood pressure (BP) in patients with controlled hypertension. However, the studies are not adequately powered to provide evidence about whether this rise in systolic BP is linked to patient-oriented outcomes (strength of recommendation: C, multiple randomized controlled trials supporting disease-oriented evidence). Significant variations in BP are defined differently among studies. In addition, we do not have data on chronic use of oral decongestants; the longest time on medication in these trials was 4 weeks.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
oral decongestants
8
clinical inquiry
4
inquiry oral
4
decongestants clinically
4
clinically patients
4
patients hypertension?
4
hypertension? unclear
4
unclear pseudoephedrine
4
pseudoephedrine average
4
average increase
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!